MARTELLI, Massimo Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 9.060
EU - Europa 6.515
AS - Asia 5.734
SA - Sud America 926
Continente sconosciuto - Info sul continente non disponibili 483
AF - Africa 148
OC - Oceania 5
Totale 22.871
Nazione #
US - Stati Uniti d'America 8.842
SG - Singapore 2.636
UA - Ucraina 1.145
IE - Irlanda 1.062
SE - Svezia 862
CN - Cina 803
RU - Federazione Russa 781
HK - Hong Kong 713
IT - Italia 712
BR - Brasile 695
VN - Vietnam 561
DE - Germania 525
FI - Finlandia 419
FR - Francia 333
KR - Corea 294
GB - Regno Unito 270
IN - India 135
CA - Canada 113
BD - Bangladesh 98
TR - Turchia 91
AR - Argentina 86
IQ - Iraq 66
BE - Belgio 60
MX - Messico 54
PL - Polonia 54
NL - Olanda 51
ZA - Sudafrica 49
UZ - Uzbekistan 46
JP - Giappone 44
AT - Austria 42
CZ - Repubblica Ceca 41
PK - Pakistan 38
CO - Colombia 35
EC - Ecuador 31
CH - Svizzera 29
ID - Indonesia 27
SA - Arabia Saudita 27
ES - Italia 25
VE - Venezuela 23
JO - Giordania 21
MA - Marocco 19
LT - Lituania 18
RO - Romania 18
CL - Cile 17
PH - Filippine 17
GR - Grecia 16
BO - Bolivia 14
PY - Paraguay 14
KE - Kenya 13
LB - Libano 13
DZ - Algeria 12
EG - Egitto 12
TN - Tunisia 12
CR - Costa Rica 11
MY - Malesia 11
IL - Israele 10
AE - Emirati Arabi Uniti 9
ET - Etiopia 9
JM - Giamaica 9
OM - Oman 9
AL - Albania 8
AZ - Azerbaigian 8
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
EU - Europa 7
KZ - Kazakistan 7
BG - Bulgaria 6
NP - Nepal 6
PT - Portogallo 6
KG - Kirghizistan 5
PE - Perù 5
AU - Australia 4
DK - Danimarca 4
GE - Georgia 4
HN - Honduras 4
HR - Croazia 4
RS - Serbia 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
EE - Estonia 3
GT - Guatemala 3
KW - Kuwait 3
MM - Myanmar 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
GD - Grenada 2
GY - Guiana 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
Totale 22.357
Città #
Singapore 1.867
Chandler 1.232
Dublin 1.062
San Jose 769
Hong Kong 709
San Mateo 670
Jacksonville 636
Ashburn 556
Boardman 396
Santa Clara 319
Ann Arbor 304
Seoul 288
Moscow 248
Medford 226
Princeton 224
Beijing 221
Dong Ket 215
Lauterbourg 199
Altamura 191
Perugia 175
Wilmington 165
Andover 161
Los Angeles 153
Munich 152
New York 152
Lawrence 140
Piscataway 124
Helsinki 115
Ho Chi Minh City 104
The Dalles 80
Turku 80
Hanoi 64
Woodbridge 63
Saint Petersburg 62
Brussels 57
São Paulo 55
Norwalk 54
Orem 51
Frankfurt am Main 47
Houston 47
Shanghai 47
Des Moines 42
London 42
Tokyo 42
Montreal 40
Council Bluffs 37
Dallas 37
Brooklyn 34
Dearborn 34
Izmir 33
San Paolo di Civitate 32
Milan 31
Stockholm 31
Warsaw 31
Atlanta 30
Johannesburg 30
Phoenix 29
Denver 28
Baghdad 27
Amsterdam 26
Auburn Hills 26
Falkenstein 25
Chennai 24
Rio de Janeiro 24
Brno 23
Rome 23
Chicago 22
San Francisco 21
Redwood City 20
Tashkent 20
Boston 19
Nuremberg 19
San Diego 19
Mexico City 18
Toronto 18
Bologna 17
Charlotte 17
Da Nang 17
Foligno 17
Quito 17
Amman 16
Ankara 15
Belo Horizonte 15
Hefei 15
Manchester 15
Brasília 14
Lahore 14
Guangzhou 13
New Delhi 13
Poplar 13
Buenos Aires 12
Espoo 12
Falls Church 12
Haiphong 12
Redmond 12
Campinas 11
Dhaka 11
Istanbul 11
Mumbai 11
Nairobi 11
Totale 13.780
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 188
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 174
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 173
Innate immunity against hematological malignancies 163
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 159
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 158
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 158
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults 151
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 150
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 150
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 146
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 146
A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma 146
14q+ chromosome marker in a T-cell-rich B-cell lymphoma. 144
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 144
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 142
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 140
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light 139
Graft engineering for allogeneic haploidentical stem cell transplantation 137
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 133
Acute lymphoblastic leukaemia in Noonan syndrome 132
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 130
Mesenchymal cells: a vehicle for gene therapy 127
Fourth international workshop on haploidentical transplants, Naples, Italy 127
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 126
"Designed" grafts for HLA-haploidentical stem cell transplantation. 126
3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus. 125
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 125
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 124
5q- syndrome termi¬nating in acute myeloid leukemia: karyotype evolution and immunological characterization of blast cells. 124
A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement 124
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 124
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 123
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 122
5q- syndrome in a patient with chronic exposure to ionizing radiation. 122
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 122
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 122
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 122
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 121
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 121
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 120
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 119
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 119
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 119
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 118
t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia 118
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 118
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 117
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 117
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 116
Regions of juxtaposition in unbalanced 1q rearrangements of malignant hemopathies 116
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases 116
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 115
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 115
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 115
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 114
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 113
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 113
T regulatory cell separation for clinical application. 113
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 112
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 111
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 111
Decreased bone mineral density after autologous stem cell transplantation. 109
A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene 109
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 109
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 108
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 107
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 107
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 107
Allogeneic transplantation across the HLA barriers. 107
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 106
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 106
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 106
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 106
AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer 106
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 106
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 105
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 105
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 105
. Mismatched hematopoietic stem cell transplants in elderly patients. 105
Transplants across human leukocyte antigen barriers 104
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells 104
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 104
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 104
The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects 103
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 102
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 102
Submicroscopic deletions in 5q- associated malignancies 102
Natural killer cell alloreactivity for leukemia therapy. 102
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 102
Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia 101
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 100
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 99
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 99
Quantitative detection of NPM1 mutations as marker of minimal residual disease (MRD) in the large majority of AML with normal karyotype 99
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 99
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 99
Stem cell mobilization in normal donors. 98
Different genomic imbalances in low- and high-grade HCV-related lymphomas 98
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 98
Totale 12.013
Categoria #
all - tutte 100.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.114 0 525 71 175 94 11 30 620 18 39 266 265
2022/20233.658 253 631 26 336 276 384 4 200 1.391 12 113 32
2023/20241.503 85 156 64 31 10 20 320 43 197 40 251 286
2024/20253.323 93 347 136 156 446 144 91 251 619 185 565 290
2025/20267.350 535 476 336 974 1.056 728 1.181 371 823 648 159 63
2026/2027325 122 203 0 0 0 0 0 0 0 0 0 0
Totale 22.871